EG BioMed has been closely collaborating with the Health Management Center of Shuang Ho Hospital. During a recent key meeting, Director Dr. Shih-Yu Ko and Deputy Director Dr. Chen enthusiastically praised and endorsed the early detection technology for pancreatic, colorectal, and lung cancers developed by EG BioMed. This groundbreaking technology, which achieves 90%-99% sensitivity, specificity,…

The EGBioMed clinical team recently held a important meeting with Dr. Yao-Yu Hsieh, Director of the Department of Hematology/Oncology at Shuang Ho Hospital. Dr. Hsieh, a leading expert in the field, has shown strong support for the recruitment of pancreatic cancer patients and the implementation of a three-month follow-up blood test as part of ongoing…

2020/08/07 Breast cancer is the most common cancer among women in Taiwan, but limited by technology, when women have abnormalities in ultrasound and X-rays, they can only find out whether they have cancer through biopsy. Peking University has developed blood breast cancer detection technology, hoping to help Breast cancer screening. On the 6th, Taipei Medical…